GlobeNewswire

Medtronic and Foxconn Partner to Increase Ventilator Production

Share
  • Companies Aim to Produce 10,000 Puritan Bennett™ 560 Ventilators Together in the United States Over the Next Year
  • Partnership Established after Medtronic Announces Ventilator Open Source Initiative

DUBLIN and MOUNT PLEASANT, Wis., June 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) and Foxconn Industrial Internet, a business group within Foxconn Technology Group (Foxconn), announced today that Foxconn has successfully completed Medtronic’s regulatory and quality requirements necessary to begin manufacturing Medtronic Puritan Bennett™ 560 (PB560) ventilators for Medtronic in the United States. Medtronic and Foxconn are currently ramping up plans to produce 10,000 PB560 ventilators over the next year at Foxconn’s Wisconn Valley Science and Technology Park in Mount Pleasant, Wis. The ventilators will be marketed and sold by Medtronic.

“No single company can meet the current demands for ventilators that are critical in the fight against COVID-19. Joining together with Foxconn immediately increases our production capacity to meet the increased demand and creates a flexible manufacturing model for us,” said Vafa Jamali, senior vice president and president of the Respiratory, Gastrointestinal and Informatics business, which is part of the Minimally Invasive Therapies Group at Medtronic. “Together, we can increase ventilator supply and help more patients and clinicians than any one company can do alone.”

“Foxconn is grateful to all front-line professionals who tirelessly work to serve others and is proud to partner with Medtronic to address this global pandemic. Foxconn’s manufacturing capabilities can bring to market life-saving medical equipment during these challenging times,” said Foo-Ming Fu, CEO of Foxconn Industrial Internet Wisconsin. “Foxconn’s flexibility to quickly react to global markets makes opportunities with partners like this possible. In the last two months, we went from zero ventilator manufacturing capabilities to a tested, qualified ventilator manufacturing cell.”

The two companies connected after Medtronic publicly shared the design specifications for the PB560 through the Medtronic ventilator open source initiative, which launched earlier this year. This effort allows global participants to evaluate options for rapid ventilator manufacturing at scale to help doctors treat patients fighting COVID-19. To date, there have been more than 200,000 registrations for the design specifications at Medtronic.com/openventilator.

To respond to global demand, if needed, Medtronic and Foxconn can increase their production capability to more than double the current Foxconn ventilator commitment.

Introduced in 2010, the PB560 is sold in more than 35 countries around the world. It is a compact, lightweight, and portable ventilator that provides airway support for both adults and children. It can be used in clinical settings and at home and provides mobile respiratory support.

Ventilators play a critical role in the management of patients with severe respiratory illness, such as COVID-19, who require assistance because they cannot breathe effectively. Without ventilation support, some patients with severe respiratory disease might not survive. By placing a patient on a ventilator, the patient’s lungs are permitted to rest and recover while the ventilator performs the functions of supplying oxygen and simulating the actions of breathing.

About Foxconn
Established in 1974, Foxconn Technology Group (“Foxconn”) is a leading technological solution provider, that has leveraged its expertise in software and hardware to integrate its unique manufacturing systems with emerging technologies.

By capitalizing on its expertise in Cloud Computing, Mobile Devices, IoT, Big Data, AI, Smart Networks and Robotics/Automation, the Group has expanded capabilities in four key technologies – Data Tech, Analytics Tech, Platform Tech, and Operations Tech. The company has research centers and testing laboratories internationally and has received more than 83,500 patents worldwide. In addition to maximizing value-creation for customers, Foxconn is also dedicated to enhancing the concept of environmental sustainability in the manufacturing process and serving as a best-practices model for global enterprises.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to the impact of COVID-19 on our business, operations and production, as well as demand for our offerings, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the Company’s periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the Company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words, such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “looking ahead,” “may,” “plan,” “possible,” “potential,” “project,” “should,” “will,” and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.

-end-


John Jordan
Medtronic plc
Public Relations
+1-508-452-4891

Ryan Weispfenning
Medtronic plc
Investor Relations
+1-763-505-4626

Robert Schlaeger
Foxconn
Public Relations
media@foxconn.com


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Basilea reports data from poster presentations at ESMO Virtual Congress 202022.9.2020 07:15:00 CESTPress release

Gene expression data may explain differences inclinical adverse event profiles ofFGFR inhibitorsAntitumor activity of derazantinibin preclinical cancer models with FGFR aberrationssupportsplanned gastric cancerstudyFull resultsfrom the completed phase 1 study in patients with brain cancer underscores the potential for lisavanbulin to be developed in a targeted patient populationusing end-binding protein 1 (EB1) as a patient selection criterion Basel, Switzerland, September22, 2020 Basilea Pharmaceutica Ltd. (SIX: BSLN) today reports on several e-posters with new preclinical and clinical data on its fibroblast growth factor receptor (FGFR) inhibitor derazantinib and its tumor checkpoint controller, lisavanbulin, presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which took place from 19-21 September, 2020. A preclinical study showed that treatment-specific gene expression patterns in tumor models may help elucidating the biological processes driving dif

EVS Broadcast Equipment reports update of share buyback program21.9.2020 17:45:00 CESTPress release

Publication on September 21, 2020, after market closing Regulated information – reporting share buyback EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS reports update of share buyback program EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on May 6, 2020, took place between September 14, 2020 and September 18, 2020. DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)14/09/20204,04014.895615.1214.58 60,178 15/09/20204,97414.683414.8014.60 73,035 16/09/20205,12314.546714.9814.30 74,523 17/09/20205,50014.481814.8814.20 79,650 18/09/20205,95014.122714.3413.86 84,030 Total25,587 14.5158 15.12 13.86 371,416 As of September 18, 2020, and since the start of the buyback program, EVS has bought 231,649 shares at an average price of EUR 15,4224, representing in total EUR 3,572,576. After aforementioned transactions

ASMI Share Buyback Update September 14 – 18, 202021.9.2020 17:45:00 CESTPress release

Almere, The Netherlands September 21, 2020, 5:45 p.m. CET ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASMI's current share buyback program. DateRepurchased sharesAverage priceRepurchased valueSeptember 14, 2020---September 15, 2020---September 16, 20206,000€ 122.37€ 734,241September 17, 202015,000€ 117.84€ 1,767,600September 18, 202025,000€ 119.53€ 2,988,128Total46,000€ 119.35€ 5,489,969 These repurchases were made as part of the €100 million share buyback program announced on June 2, 2020. Of the total program, 32.6% has been repurchased. For further details including individual transaction information please visit: www.asm.com/investors/share-information/share-buyback. About ASM International ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participation

Completion of vessel sale21.9.2020 17:12:01 CESTPress release

Bermuda, 21 September 2020 - Avance Gas Holding Ltd (OSE: AVANCE) refer to the press release dated 4 August 2020, the transaction for the sale of the 2003-built VLGC Avance was successfully completed today. Following repayment of debt, the transaction will generate approx. $17 million in net cash proceeds, with a book profit of approx. $6 million to be recorded in the third quarter. The sale follows the company’s fleet renewal strategy, reducing average age and improving the fuel efficiency of the overall fleet which was also complemented by the contracting of two 91,000 cbm LPG dual fuel newbuilding’s to be delivered in 2021/2022. For further queries, please contact: Randi Navdal Bekkelund, CFO Tel: +47 22 00 48 29 About Avance Gas Avance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world's leading owners and operators of very large gas carrier (VLGC), and operates a fleet of thirteen modern ships and two Dual Fuel LP

Real People Investment Holdings Limited: Results from the written procedure initiated on 9 September 202021.9.2020 17:00:00 CESTPress release

Real People Investment Holdings Limited's ("RPIH") requests to approve amendments to the terms and conditions of its SEK and NOK bonds have been approved. On 9 September 2020, RPIH instructed Nordic Trustee & Agency AB (publ) (the "Agent") to initiate a written procedure for RPIH's up to SEK 260,000,000 and NOK 135,000,000 senior unsecured callable bonds with ISIN SE0005392560 and NO0010689342 (the "Bonds") in order to request (the "Requests") that the bondholders agree to that, inter alia: the final maturity date shall be extended to 31 March 2028; the scheduled specified amortisations shall be replaced by a minimum repayment undertaking pursuant to which RPIH shall ensure that the Capital Nominal Amount (as defined in the Terms and Conditions) does not exceed: 92 percent. of the Initial Capital Nominal Amount (as defined in Schedule 3 (Amended and Restated Terms and Conditions) in the notice of written procedure) on 31 March 2023;77 percent. of the Initial Capital Nominal Amount on 3

Organisational changes and ESG investor seminar21.9.2020 16:30:00 CESTPress release

Oslo, 21 September 2020: Yara makes organisational changes effective 1 October, and announces an ESG investor seminar to be held 3 December 2020. “The organisational changes we make today support Yara’s ongoing transition towards providing sustainable solutions for the global food system, and we look forward to presenting the next steps in our transition during our ESG investor seminar later this year,” said Svein Tore Holsether, President & CEO. Lair Hanzen, currently EVP Yara Americas, is appointed Special Advisor to the President & CEO, reporting to Svein Tore Holsether and relocating to Oslo. Hanzen will support Yara’s ongoing activities within green ammonia, building on our leading position in ammonia production technology and distribution, and will in this capacity report to EVP Farming Solutions Terje Knutsen. Hanzen will also initiate a review of Yara’s asset base in the context of the ongoing transition, initially focusing on Yara’s mining projects. Chrystel Monthean, currentl